Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Ranirestat> ?p ?o. }
Showing items 1 to 36 of
36
with 100 items per page.
- Ranirestat abstract "Ranirestat (AS-3201) is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy by Dainippon Sumitomo Pharma and PharmaKyorin. It has been granted orphan drug status. The drug is to be used orally.".
- Ranirestat fdaUniiCode "Z26P56GFTV".
- Ranirestat iupacName "(3R)-2'-(4-bromo-2-fluorobenzyl)-1H,2H,5H-spiro[pyrrolidine-3,4'-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2H)-tetrone".
- Ranirestat thumbnail Ranirestat_stereo.png?width=300.
- Ranirestat wikiPageID "12839039".
- Ranirestat wikiPageRevisionID "544918066".
- Ranirestat hasPhotoCollection Ranirestat.
- Ranirestat imagefile "Ranirestat_stereo.png".
- Ranirestat iupacname "-2".
- Ranirestat unii "Z26P56GFTV".
- Ranirestat verifiedrevid "437206457".
- Ranirestat subject Category:Aldose_reductase_inhibitors.
- Ranirestat subject Category:Orphan_drugs.
- Ranirestat type Agent114778436.
- Ranirestat type AldoseReductaseInhibitors.
- Ranirestat type CausalAgent100007347.
- Ranirestat type Drug103247620.
- Ranirestat type Inhibitor114724436.
- Ranirestat type Matter100020827.
- Ranirestat type OrphanDrugs.
- Ranirestat type PhysicalEntity100001930.
- Ranirestat type Substance100020090.
- Ranirestat type ChemicalCompound.
- Ranirestat type ChemicalSubstance.
- Ranirestat type ChemicalSubstanceType.
- Ranirestat type ChemicalObject.
- Ranirestat type Thing.
- Ranirestat comment "Ranirestat (AS-3201) is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy by Dainippon Sumitomo Pharma and PharmaKyorin. It has been granted orphan drug status. The drug is to be used orally.".
- Ranirestat label "Ranirestat".
- Ranirestat sameAs m.02x72th.
- Ranirestat sameAs Q7293074.
- Ranirestat sameAs Q7293074.
- Ranirestat sameAs Ranirestat.
- Ranirestat wasDerivedFrom Ranirestat?oldid=544918066.
- Ranirestat depiction Ranirestat_stereo.png.
- Ranirestat isPrimaryTopicOf Ranirestat.